Complete Filing Data
Stellus Capital Investment Corp reported Stock Issued During Period Shares New Issues of 1.47 million shares for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Stellus Capital Investment Corp did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Other Selling General And Administrative Expense | $1.2M | $1.2M | $891.2K | $984.3K | $1.0M | $890.5K |
| Operating Expenses | $68.6M | $64.6M | $63.9M | $46.5M | $43.9M | $34.7M |
| Net Income Loss | $27.0M | $45.8M | $17.5M | $14.5M | $33.6M | $20.2M |
| Income Tax Expense Benefit | $1.6M | $1.8M | $1.3M | $1.2M | $1.1M | $771.1K |
| General And Administrative Expense | $2.1M | $1.9M | $1.9M | $1.8M | $1.8M | $1.8M |
| Deferred Income Tax Expense Benefit | $0.00 | -$188.9K | $127.0K | $213.2K | -$510.9K | $224.9K |
| Income Taxes Paid Net | $1.7M | $1.8M | $2.5M | $3.3M | $1.4M | $940.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Selling General And Administrative Expense | $227.0K | $500.3K | $218.4K | $245.0K | $417.9K | $245.3K | $217.7K | $331.6K | $178.5K | $207.2K | $347.7K | $211.7K | $209.8K |
| Operating Expenses | $17.6M | $17.1M | $16.4M | $16.2M | $16.5M | $16.0M | $16.3M | $16.2M | $15.0M | $13.0M | $9.9M | $10.0M | $13.0M |
| Net Income Loss | $6.7M | $10.1M | $5.0M | $15.5M | $8.5M | $13.1M | -$2.4M | $3.7M | $4.7M | $4.0M | $1.3M | $5.2M | $12.8M |
| Income Tax Expense Benefit | $515.7K | $429.0K | $499.5K | $360.2K | $574.0K | $370.7K | $335.5K | $371.8K | $374.8K | $361.1K | $426.2K | $279.4K | $192.6K |
| General And Administrative Expense | $592.4K | $474.3K | $449.3K | $469.3K | $481.3K | $490.9K | $470.8K | $466.4K | $462.0K | $447.4K | $466.9K | $474.3K | $437.8K |
| Deferred Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | -$381.5K | $192.6K | -$312.00 | $65.4K | $78.8K | -$30.5K | $160.7K | $21.2K | $606.4K | |
| Income Taxes Paid Net | $1.6M | $1.5M | $303.00 | $1.0M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $371.2M | $369.9M | $319.9M | $275.8M | $285.1M | $273.4M | $270.6M | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $25.1M | $20.1M | $26.1M | $48.0M | $44.2M | $18.5M | $16.1M | ||||||
| Assets Net | $371.2M | $369.9M | $319.9M | $275.8M | $285.1M | $273.4M | $270.6M | $224.8M | $220.2M | $170.9M | $164.7M | $173.9M | $175.9M |
| Unrealized Gain Loss On Investments | -$11.1M | $19.6M | $2.8M | -$17.5M | -$6.9M | $8.6M | |||||||
| Notes Payable | $122.7M | $99.4M | $99.0M | $98.5M | $100.0M | $48.9M | $48.9M | $48.9M | $48.9M | $25.0M | $25.0M | $25.0M | $110.0M |
| Debt And Equity Securities Unrealized Gain Loss | $18.7M | $3.2M | -$17.5M | -$6.9M | $8.6M | ||||||||
| Amortization Of Debt Discount Premium | $96.1K | -$2.7M | -$2.7M | -$2.5M | -$2.4M | -$2.1M | |||||||
| Net Realized Gains Losses On Investments Cash Flow Impacts | -$1.5M | $15.7M | $30.2M | -$3.7M | -$23.7M | $10.1M | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $5.0M | -$6.1M | -$21.9M | $3.9M | $25.7M | $2.3M | |||||||
| Receivable Investment Sale | $581.5K | $335.7K | $371.9K | $718.8K | $536.1K | ||||||||
| Percentage Of Net Assets | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | ||||||||
| Net Investment Percentage Of Net Assets | 271.5% | 257.8% | 273.3% | 306.3% | 271.1% | ||||||||
| Management Fee Payable | $4.4M | $4.0M | $2.9M | $7.2M | $3.5M | ||||||||
| Liabilities In Excess Of Other Assets Percentage Of Net Assets | -171.5% | -157.8% | -173.3% | -206.3% | -171.1% | ||||||||
| Liabilities And Stockholders Equity | $1.04B | $980.9M | $908.1M | $898.2M | $821.3M | ||||||||
| Liabilities | $670.1M | $611.0M | $588.1M | $622.4M | $536.2M | ||||||||
| Interest Payable Current And Noncurrent | $6.1M | $5.3M | $5.2M | $4.6M | $3.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $377.7M | $375.4M | $372.8M | $366.3M | $347.2M | $323.4M | $318.1M | $308.3M | $280.9M | $277.2M | $279.9M | $285.0M | $275.6M | $274.2M | $273.4M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $9.0M | $40.0M | $10.9M | $38.6M | $35.9M | $48.8M | $19.2M | $14.9M | $17.9M | $12.4M | $26.5M | $24.6M | $37.8M | ||
| Assets Net | $377.7M | $375.4M | $372.8M | $366.3M | $347.2M | $323.4M | $318.1M | $308.3M | $280.9M | $277.2M | $279.9M | $285.0M | $275.6M | ||
| Unrealized Gain Loss On Investments | -$5.1M | $1.4M | $1.2M | $8.5M | -$5.6M | $23.5M | -$13.8M | -$6.3M | -$4.2M | -$4.8M | -$4.3M | -$3.7M | $2.1M | $1.7M | $122.0K |
| Notes Payable | $172.5M | $172.3M | $99.6M | $99.3M | $99.2M | $99.1M | $98.9M | $98.8M | $100.0M | $100.0M | $100.0M | $100.0M | |||
| Debt And Equity Securities Unrealized Gain Loss | -$5.2M | $143.2K | $1.1M | $8.3M | -$5.7M | $23.0M | -$13.8M | -$6.3M | -$4.2M | -$4.8M | -$4.3M | -$3.7M | $2.1M | ||
| Amortization Of Debt Discount Premium | -$715.8K | -$702.5K | -$666.0K | -$546.8K | |||||||||||
| Net Realized Gains Losses On Investments Cash Flow Impacts | $6.0M | $20.4M | -$35.0K | -$3.5M | |||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$9.2M | $22.6M | -$30.2M | -$19.5M | |||||||||||
| Receivable Investment Sale | $437.6K | $399.1K | $446.6K | $1.4M | $574.0K | $776.4K | $594.7K | $207.1K | $777.6K | $562.1K | |||||
| Percentage Of Net Assets | 100.0% | 100.0% | 100.0% | ||||||||||||
| Net Investment Percentage Of Net Assets | 267.4% | 262.6% | 265.9% | 248.1% | 259.1% | 270.8% | 278.6% | 286.0% | 312.4% | 3.5% | |||||
| Management Fee Payable | $4.4M | $4.3M | $4.1M | $4.0M | $852.2K | $1.9M | $3.9M | $1.9M | $4.6M | $7.0M | |||||
| Liabilities In Excess Of Other Assets Percentage Of Net Assets | -165.9% | -170.8% | -212.4% | ||||||||||||
| Liabilities And Stockholders Equity | $1.03B | $1.03B | $1.01B | $957.1M | $946.5M | $935.2M | $912.0M | $901.8M | $900.9M | $889.1M | |||||
| Liabilities | $650.9M | $659.4M | $639.0M | $590.8M | $599.3M | $611.8M | $593.8M | $593.4M | $620.0M | $611.9M | |||||
| Interest Payable Current And Noncurrent | $5.9M | $6.5M | $1.5M | $1.3M | $5.2M | $1.5M | $1.3M | $4.8M | $1.2M | $885.3K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Proceeds From Issuance Of Common Stock | $20.6M | $46.5M | $63.3M | $2.2M | $449.5K | $4.8M |
| Proceeds From Lines Of Credit | $300.6M | $187.9M | $108.4M | $149.9M | $268.7M | $121.0M |
| Proceeds From Disposition Of Investment Operating Activity | $139.7M | $151.8M | $134.2M | $127.5M | $287.6M | $128.6M |
| Payments Of Dividends | $45.3M | $37.6M | $35.5M | $26.6M | $21.0M | $24.3M |
| Payments For Purchase Of Investment Operating Activity | $194.1M | $221.2M | $183.9M | $211.0M | $387.3M | $152.0M |
| Net Cash Provided By Used In Operating Activities | -$24.4M | -$28.6M | -$17.3M | -$56.3M | -$76.1M | -$3.5M |
| Net Cash Provided By Used In Financing Activities | $29.4M | $22.6M | -$4.7M | $60.2M | $101.8M | $5.8M |
| Increase Decrease In Prepaid Expense | -$516.0K | $60.2K | -$60.6K | $155.1K | $25.0K | $119.0K |
| Increase Decrease In Other Employee Related Liabilities | $145.8K | -$8.6K | $45.2K | -$29.4K | -$5.1K | -$21.8K |
| Increase Decrease In Other Accrued Liabilities | -$565.0K | $659.0K | -$197.2K | $136.6K | $164.2K | -$28.7K |
| Increase Decrease In Interest Payable Net | $856.7K | $40.2K | $600.3K | $947.2K | $1.5M | -$178.2K |
| Increase Decrease In Deferred Revenue | $33.4K | $150.9K | $77.1K | -$209.1K | $6.3K | -$36.3K |
| Increase Decrease In Accrued Interest Receivable Net | $1.4M | $65.4K | $897.9K | $1.0M | $755.2K | -$725.3K |
| Payments Of Stock Issuance Costs | $606.8K | $428.1K | $253.9K | $517.1K | $53.3K | $95.7K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Proceeds From Issuance Of Common Stock | $9.3M | $8.5M | $221.2K | |
| Proceeds From Lines Of Credit | $67.7M | $50.0M | $13.3M | $57.4M |
| Proceeds From Disposition Of Investment Operating Activity | $15.0M | $31.2M | $5.9M | $10.0M |
| Payments Of Dividends | $11.0M | $6.4M | $5.3M | $4.4M |
| Payments For Purchase Of Investment Operating Activity | $55.4M | $28.5M | $41.2M | $74.5M |
| Net Cash Provided By Used In Operating Activities | -$36.9M | $4.5M | -$32.0M | -$62.9M |
| Net Cash Provided By Used In Financing Activities | $27.8M | $18.2M | $1.9M | $43.4M |
| Increase Decrease In Prepaid Expense | -$90.3K | -$21.3K | -$148.4K | -$10.0K |
| Increase Decrease In Other Employee Related Liabilities | -$13.0K | $22.9K | $40.0K | $18.3K |
| Increase Decrease In Other Accrued Liabilities | $989.4K | -$61.7K | -$78.9K | $482.6K |
| Increase Decrease In Interest Payable Net | -$3.8M | -$3.7M | -$3.4M | -$2.9M |
| Increase Decrease In Deferred Revenue | $72.2K | $14.6K | -$47.6K | -$62.7K |
| Increase Decrease In Accrued Interest Receivable Net | $1.3M | $1.6M | $187.4K | -$179.9K |
| Payments Of Stock Issuance Costs | $180.0K | $5.2K | $73.0K | $50.4K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Asset Value Per Share | $12.82 | $13.46 | $13.26 | $14.02 | $14.61 | $14.03 | $14.14 | $14.09 | $13.81 | $13.69 | $13.19 | $13.94 | $14.54 | $14.45 |
| Weighted Average Number Of Shares Outstanding Basic | 28.4M | 25.6M | 22.0M | 19.6M | 19.5M | 19.5M | 18.3M | 16.0M | 14.9M | 12.5M | 12.5M | 12.3M | 12.1M | |
| Weighted Average Number Of Diluted Shares Outstanding | 28.4M | 25.6M | 22.0M | 19.6M | 19.5M | 19.5M | 19.5M | 18.3M | 16.0M | 14.9M | 12.5M | 12.3M | 12.1M | |
| Earnings Per Share Diluted | $0.95 | $1.79 | $0.80 | $0.74 | $1.72 | $1.04 | ||||||||
| Earnings Per Share Basic | $0.95 | $1.79 | $0.80 | $0.74 | $1.72 | $1.04 | ||||||||
| Common Stock Dividends Per Share Cash Paid | $1.60 | $1.61 | $1.61 | $1.30 | $1.14 | $1.15 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Asset Value Per Share | $13.05 | $13.21 | $13.25 | $13.55 | $13.36 | $13.41 | $13.19 | $13.67 | $13.87 | $14.18 | $14.32 | $14.59 | $14.15 |
| Weighted Average Number Of Shares Outstanding Basic | 28.5M | 28.4M | 27.6M | 26.3M | 24.7M | 24.1M | 22.8M | 21.2M | 19.8M | 19.5M | 19.5M | 19.5M | 19.5M |
| Weighted Average Number Of Diluted Shares Outstanding | 28.5M | 28.4M | 27.6M | 26.3M | 24.7M | 24.1M | 22.8M | 21.2M | 19.8M | 19.5M | 19.5M | 19.5M | 19.5M |
| Earnings Per Share Diluted | $0.23 | $0.36 | $0.18 | $0.59 | $0.35 | $0.54 | $-0.11 | $0.17 | $0.24 | $0.20 | $0.07 | $0.27 | $0.66 |
| Earnings Per Share Basic | $0.23 | $0.36 | $0.18 | $0.59 | $0.35 | $0.54 | $-0.11 | $0.17 | $0.24 | $0.20 | $0.07 | $0.27 | $0.66 |
| Common Stock Dividends Per Share Cash Paid | $0.40 | $0.40 | $0.40 | $0.40 | $0.41 | $0.40 | $0.41 | $0.41 | $0.40 | $0.34 | $0.34 | $0.28 | $0.58 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Shares New Issues | 1.5M | 3.4M | 4.5M | 149.2K | 31.6K | 354.3K | 3.2M | 7.9K | 3.5M | 380.9K | 64.0K | 12.0M | ||
| Incometaxexpensebenefitdebtandequitysecuritiesunrealizedgainloss | -$188.9K | $127.0K | $213.2K | -$510.9K | $224.9K | $66.8K | -$373.1K | $93.6K | $288.1K | |||||
| Investment Income Operating After Expense And Tax | $36.9M | $41.9M | $42.2M | $28.6M | $19.8M | $22.0M | ||||||||
| Realized Investment Gains Losses | -$15.7M | -$30.2M | $3.7M | $23.7M | -$10.1M | |||||||||
| Valuationfeeexpense | $407.4K | $380.2K | $373.6K | $351.8K | $313.4K | $290.4K | ||||||||
| Professional Fees | $1.9M | $1.2M | $1.5M | $1.1M | $1.1M | $950.7K | ||||||||
| Netinvestmentincomepersharebasic | $1.30 | $1.64 | $1.92 | $1.46 | $1.01 | $1.13 | ||||||||
| Net Investment Income | $36.9M | $41.9M | $42.2M | $28.6M | $19.8M | $22.0M | ||||||||
| Management Fee Expense | $17.2M | $15.7M | $15.5M | $14.8M | $13.2M | $11.1M | ||||||||
| General Insurance Expense | $396.9K | $499.9K | $492.6K | $503.9K | $482.1K | $384.8K | ||||||||
| Directorsfees | $409.0K | $412.0K | $406.0K | $329.0K | $315.0K | $394.8K | ||||||||
| Unrealized Gain Loss Investment And Derivative Operating Tax Expense Benefit | -$188.9K | $127.0K | $213.2K | -$510.9K | $224.9K | |||||||||
| Netinvestmentincomepersharediluted | $1.64 | $1.92 | $1.46 | $1.01 | $1.13 | |||||||||
| Incomeincentiveexpense | $8.4M | $10.0M | $10.2M | $3.8M | $3.0M | $2.5M | ||||||||
| Stock Issued During Period Value New Issues | $19.7M | $45.4M | $62.2M | $1.6M | $393.7K | $5.0M | ||||||||
| Foreign Currency Transaction Gain Loss Realized After Tax | -$68.8K | -$94.7K | -$112.5K | -$6.1K | ||||||||||
| Foreign Currency Transaction Gain Loss Realized | -$68.8K | -$94.7K | -$112.5K | -$6.1K | ||||||||||
| Foreign Currency Transaction Gain Loss Unrealized After Tax | $33.1K | -$14.8K | -$6.5K | $6.0K | ||||||||||
| Foreign Currency Transaction Gain Loss Unrealized Excluding Investment Price Change Before Tax | $33.1K | -$14.8K | -$6.5K | $6.0K | ||||||||||
| Gross Investment Income Operating | $75.1M | $63.7M | $56.7M | |||||||||||
| Investment Company Distribution Ordinary Income | $35.1M | $21.6M | $21.2M | $22.4M | ||||||||||
| Line Of Credit | $233.2M | $172.3M | $156.6M | $197.7M | $175.5M | $40.8M | $116.0M | $109.5M | $106.5M | $9.0M | ||||
| Repayments Of Lines Of Credit | $240.1M | $172.4M | $148.1M | $126.6M | $265.4M | $108.5M | ||||||||
| Interest Paid Net | $31.4M | $28.9M | $29.1M | $21.3M | $15.1M | $14.4M | ||||||||
| Increasedecreaseinmanagementfeespayable | $408.6K | $1.1M | -$4.2M | $3.7M | $628.9K | $129.5K | ||||||||
| Increasedecreaseinincomeincentivefeespayable | -$792.1K | $224.4K | $420.8K | $715.3K | $1.1M | -$936.8K | ||||||||
| Amortizationofloanstructurefees | $1.2M | $1.1M | $657.3K | $567.4K | $518.9K | $647.9K | ||||||||
| Amortizationoffinancingcostsguaranteeddebt | $732.1K | $978.6K | $1.3M | $1.2M | $1.1M | $701.1K | ||||||||
| Amortization Of Financing Costs | $692.4K | $447.9K | $446.7K | $446.7K | $444.2K | $333.3K | ||||||||
| Paymentsofcommonstocksalesloads | $309.0K | $698.2K | $943.2K | $31.1K | $2.5K | $18.2K | ||||||||
| Investment Company Expense After Reduction Of Fee Waiver And Reimbursement | $65.3M | $62.8M | $63.6M | $46.5M | $43.9M | |||||||||
| Prepaid Expense Current And Noncurrent | $150.8K | $666.9K | $606.7K | $667.3K | $512.2K | |||||||||
| Investment Owned At Fair Value | $1.01B | $953.5M | $874.5M | $844.7M | $772.9M | |||||||||
| Investment Owned At Cost | $1.03B | $961.8M | $902.1M | $875.8M | $785.0M | |||||||||
| Incomeincentivefeepayable | $2.3M | $3.1M | $2.9M | $2.5M | $1.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Shares New Issues | 531.1K | 278.9K | 656.1K | 1.1M | 1.9M | 2.3M | 581.6K | 13.4K | 14.9K | ||||||
| Incometaxexpensebenefitdebtandequitysecuritiesunrealizedgainloss | -$381.5K | $192.6K | $312.00 | $65.4K | $78.8K | -$30.5K | $160.7K | $21.2K | $606.4K | ||||||
| Investment Income Operating After Expense And Tax | $9.1M | $9.6M | $9.8M | $10.3M | $11.8M | $10.2M | $10.8M | $10.4M | $9.1M | $7.2M | $6.2M | $5.5M | $4.1M | $5.5M | $5.1M |
| Realized Investment Gains Losses | -$6.0M | -$3.3M | $2.0M | -$20.4M | $600.4K | -$310.6K | $35.0K | $1.6M | -$352.7K | $3.5M | $7.9M | -$1.8M | $462.2K | ||
| Valuationfeeexpense | $172.4K | $38.5K | $157.9K | $151.5K | $35.7K | $156.5K | $139.3K | $46.4K | $147.1K | $145.9K | $30.0K | $139.6K | $141.0K | ||
| Professional Fees | $395.1K | $312.8K | $418.0K | $312.0K | $196.2K | $339.6K | $276.6K | $169.8K | $430.8K | $315.8K | $217.4K | $312.1K | $267.3K | ||
| Netinvestmentincomepersharebasic | $0.32 | $0.34 | $0.35 | $0.39 | $0.48 | $0.42 | $0.47 | $0.49 | $0.46 | $0.37 | $0.32 | $0.28 | $0.21 | ||
| Net Investment Income | $9.1M | $9.6M | $9.8M | $10.3M | $11.8M | $10.2M | $10.8M | $10.4M | $9.1M | $7.2M | $6.2M | $5.5M | $4.1M | ||
| Management Fee Expense | $4.4M | $4.3M | $4.1M | $4.0M | $3.9M | $3.9M | $3.9M | $3.9M | $3.7M | $3.8M | $3.7M | $3.5M | $3.5M | ||
| General Insurance Expense | $99.2K | $98.7K | $97.1K | $126.4K | $125.5K | $125.0K | $123.7K | $121.9K | $120.5K | $127.3K | $125.9K | $124.5K | $120.1K | ||
| Directorsfees | $93.3K | $93.3K | $111.3K | $93.3K | $114.3K | $108.3K | $93.3K | $93.3K | $117.3K | $83.5K | $74.5K | $96.5K | $74.5K | ||
| Unrealized Gain Loss Investment And Derivative Operating Tax Expense Benefit | -$2.2K | -$381.5K | $192.6K | $312.00 | $65.4K | $78.8K | -$30.5K | $160.7K | $21.2K | $606.4K | -$187.7K | $167.8K | |||
| Netinvestmentincomepersharediluted | $0.32 | $0.34 | $0.35 | $0.39 | $0.48 | $0.42 | $0.47 | $0.49 | $0.46 | $0.37 | $0.32 | $0.28 | $0.21 | ||
| Incomeincentiveexpense | $2.2M | $2.2M | $2.1M | $2.6M | $2.5M | $2.5M | $2.7M | $2.6M | $2.1M | $1.6M | $1.5M | ||||
| Stock Issued During Period Value New Issues | $7.1M | $3.8M | $8.9M | $14.3M | $25.2M | $21.5M | $32.4M | $8.3M | $137.5K | $167.7K | |||||
| Foreign Currency Transaction Gain Loss Realized After Tax | -$9.4K | -$20.0K | -$29.7K | -$22.1K | -$29.8K | -$25.1K | -$22.2K | -$10.7K | -$39.9K | -$7.4K | |||||
| Foreign Currency Transaction Gain Loss Realized | -$9.4K | -$20.0K | -$29.7K | -$22.1K | -$29.8K | -$25.1K | -$22.2K | -$10.7K | -$39.9K | -$676.00 | -$7.4K | ||||
| Foreign Currency Transaction Gain Loss Unrealized After Tax | -$325.00 | $30.5K | $8.3K | $14.6K | -$5.9K | -$3.6K | -$2.8K | -$20.3K | $1.9K | -$35.8K | |||||
| Foreign Currency Transaction Gain Loss Unrealized Excluding Investment Price Change Before Tax | -$325.00 | $30.5K | $8.3K | $14.6K | -$5.9K | -$3.6K | -$2.8K | -$20.3K | $1.9K | -$18.1K | -$35.8K | ||||
| Gross Investment Income Operating | $26.3M | $25.7M | $25.0M | $26.5M | $26.6M | $26.0M | $27.2M | $26.6M | $24.1M | $20.1M | $16.1M | $15.5M | $17.0M | ||
| Investment Company Distribution Ordinary Income | $10.6M | $10.0M | $9.6M | $9.3M | $8.7M | $8.0M | $6.6M | $6.6M | $5.5M | $11.3M | $4.9M | $4.9M | |||
| Line Of Credit | $164.0M | $160.6M | $219.1M | $154.6M | $166.4M | $181.3M | $161.2M | $170.2M | $196.9M | $197.4M | |||||
| Repayments Of Lines Of Credit | $21.6M | $25.3M | $14.5M | $29.2M | |||||||||||
| Interest Paid Net | $11.4M | $10.8M | $10.8M | $7.2M | |||||||||||
| Increasedecreaseinmanagementfeespayable | $20.6K | -$1.1M | -$2.6M | $492.7K | |||||||||||
| Increasedecreaseinincomeincentivefeespayable | -$1.5M | -$140.1K | $2.1M | -$1.0M | |||||||||||
| Amortizationofloanstructurefees | $315.6K | $264.7K | $143.8K | $133.3K | |||||||||||
| Amortizationoffinancingcostsguaranteeddebt | $189.0K | $314.1K | $317.5K | $283.1K | |||||||||||
| Amortization Of Financing Costs | $110.2K | $111.4K | $110.2K | $83.7K | |||||||||||
| Paymentsofcommonstocksalesloads | $138.9K | $126.3K | $3.1K | ||||||||||||
| Investment Company Expense After Reduction Of Fee Waiver And Reimbursement | $17.1M | $16.1M | $15.2M | $16.2M | $14.8M | $15.8M | $16.3M | $16.2M | $15.0M | ||||||
| Prepaid Expense Current And Noncurrent | $281.6K | $447.9K | $576.6K | $256.7K | $412.7K | $585.4K | $149.8K | $309.7K | $518.9K | $219.1K | |||||
| Investment Owned At Fair Value | $1.01B | $985.9M | $991.1M | $908.7M | $899.7M | $875.9M | $886.3M | $881.7M | $877.5M | $871.7M | |||||
| Investment Owned At Cost | $1.02B | $990.4M | $997.8M | $909.3M | $909.5M | $880.2M | $941.7M | $922.8M | $912.6M | $899.1M | |||||
| Incomeincentivefeepayable | $2.6M | $2.1M | $1.7M | $3.2M | $1.4M | $2.7M | $3.1M | $3.2M | $4.6M | $1.9M |
Most recent annual filing with the SEC: March 11, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.